PEG
67
5
FOXA
59
4
GILD
49
2
SIG
49
6
CB
51
3
MLM
51
3
BSX
70
2
AAL
53
-4
STZ
57
2
MU
36
5
INTU
54
3
CMG
67
3
MMC
60
6
WEC
55
2
TGNA
56
3
ROP
59
5
PVH
57
5
CFG
64
2
DOW
34
4
MCD
50
-2
PEG
67
5
FOXA
59
4
GILD
49
2
SIG
49
6
CB
51
3
MLM
51
3
BSX
70
2
AAL
53
-4
STZ
57
2
MU
36
5
INTU
54
3
CMG
67
3
MMC
60
6
WEC
55
2
TGNA
56
3
ROP
59
5
PVH
57
5
CFG
64
2
DOW
34
4
MCD
50
-2
Financhill
Back

Ultragenyx Pharmaceutical Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28

RARE
Ultragenyx Pharmaceutical

Last Price:
46.00
Seasonality Move:
12.78%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Ultragenyx Pharmaceutical Price Quote

$46.00
-0.02 (-0.86%)
(Updated: November 22, 2024 at 5:18 AM ET)

Ultragenyx Pharmaceutical Key Stats

Sell
28
Ultragenyx Pharmaceutical (RARE) is a Sell
Day range:
$45.91 - $47.14
52-week range:
$37.02 - $60.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.65
P/B ratio:
12.25%
Volume:
525.3K
Avg. volume:
824.8K
1-year change:
18.49%
Market cap:
$4.2B
Revenue:
$434.2M
EPS:
$-6.47

How Much Does Ultragenyx Pharmaceutical Make?

Is Ultragenyx Pharmaceutical Growing As A Company?

Ultragenyx Pharmaceutical Stock Price Performance

What Is Ultragenyx Pharmaceutical 52-Week High & Low?

Ultragenyx Pharmaceutical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ultragenyx Pharmaceutical?

Is Ultragenyx Pharmaceutical Cash Flow Positive?

  • What Is RARE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$418.6M
  • What Is Ultragenyx Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $726.7M
  • What Is Ultragenyx Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$227.5M

Ultragenyx Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    RARE return on invested capital is -226.56%
  • What Is Ultragenyx Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is -38.86%
  • What Is RARE Return On Equity?
    ROE is a measure of profitability and is -226.56%

Ultragenyx Pharmaceutical Earnings Date & Stock Price

Ultragenyx Pharmaceutical Competitors

Ultragenyx Pharmaceutical Dividend Yield

Ultragenyx Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 4.96%
Revenue: 42.27% 3.14%

Analyst Recommendations

Buy Recommendations: 13
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 92.43
Upside from Last Price: 100.84%

Major Shareholders

  • How many RARE shares are owned by institutional investors?
    136.7M RARE shares are owned by institutional investors
  • How many RARE shares are owned by insiders?
    1.8M RARE shares are owned by insiders